Advertisement

Topics

Companies Related to "IONCs show potential next generation contrast agents" [Most Relevant Company Matches] RSS

00:55 EST 25th November 2017 | BioPortfolio

Here are the most relevant search results for "IONCs show potential next generation contrast agents" found in our extensive corporate database of over 50,000 company records.

Showing "IONCs show potential next generation contrast agents" Companies 1–25 of 2,500+

Relevant

Molecular Biosystems Inc.

Molecular Biosystems, Inc. is a leader in the development, manufacture and sale of ultrasound contrast imaging agents. These contrast agents are used primarily to improve the real-time images ("moving pictures") of organs and body structures, especially the heart, obtained through ultrasound examinations. MBI's products are designed to increase the diagnosticusefulness of ultrasound examinations t...


EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Advanced Magnetics Incorporated

Advanced Magnetics, Inc., develops, manufactures and markets organ-specific contrast agents to improve the diagnostic capabilities of soft tissue magnetic resonance imaging ("MRI") scans. Sales of the Company's liver contrast agent, FeridexI.V.(R), have commenced in Europe, Japan, the United States, Argentina, South Korea and Israel. The product is approved and awaiting market launch in China. Sal...


Endra Life Sciences

Endra Inc., based in Ann Arbor, MI, is dedicated to the commercialization of photoacoustic imaging, a groundbreaking approach enabling rapid, high contrast, high resolution functional and anatomical imaging at depth, without the need for contrast agents. Endra technologies provide fast, simple non-invasive solutions for quantification of tumor vasculature, blood oxygen saturation, and imaging o...

Molecular Templates Inc.

Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers. Such agents are derived from the sophisticated mutation and selection of Shiga-like toxin (SLT) variants using recombinant DNA ...

Guerbet LLC

Since 1901 Guerbet Group has had a long-standing tradition as a pioneer in the research and development of medical imaging contrast media. Headquartered in Paris, France, Guerbet is a publicly traded company holding more than 20% of the European market share and 7% of the worldwide contrast media market.The Guerbet product portfolio is marketed in 130 countries worldwide and contains contrast agen...

Digital Health Technology Show

Launching in 2017, The Digital Health Technology Show is the biggest show in Europe for disruptive technology and takes place 7-8 March at ExCeL in London.

Mallinckrodt plc

Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes...

Mallinckrodt Pharmaceuticals

Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes...

Show Your Logo, Inc.

Show Your Logo, Inc. offers promotional products for organizations of all sizes. The company’s impressive product line comprises over 700,000 promotional products ranging from corporate gifts and tradeshow giveaways to team apparel and sports fan favorites. Each of the company’s products can be customized with a logo or other artwork. Show Your L...

Dynamics Inc.

Dynamics Inc., founded in 2007 by Jeff Mullen, designs and manufactures intelligent battery-powered payment devices and advanced payment platforms. The company won the $1M People's Choice Award at DEMO Fall 2010, four Finovate Best of Show awards, and Best in Show for Personal Electronics at the 2011 International CES show. Dynamics investors include Adams...

HERMES Biosciences

HERMES Biosciences, Inc. was founded in 1998 to develop highly innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The HERMES vision builds upon previous accomplishments by HERMES scientists and others in the development of both liposomes and antibodies as targeting agents. Liposomes have become an important drug delivery system, with several first- an...

GANYMED Pharmaceuticals AG

GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy of current solid cancer therapeutics is severely limited, because their molecular targets are elevated in a subset of a particular cancer but they are also found widely in normal tissues. In contrast...

Wearable Technology Show

“The Wearable Technology Show continues to grow from strength to strength, breaking new boundaries in terms of our global audience, reach and content each year,” commented COO John Weir.

EPIX Medical Incorporated

Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female sexual arousal dysfunction, atherosclerosis and myocardial perfusion. In addition to MS-325, EPIX's pipeline includes a new class of MR...

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving patients’ quality of life by protecting those with chronic kidney disease from contrast induced nephropathy (CIN) and preventing limb amputation in diabetic patients with advanced ...

BOREAN PHARMA A/S

Borean Pharma is a leading Danish drug discovery and development company focused on recombinant protein technology. The Company's technology platform has the potential for design, development and production of a new generation of pharmaceutical protein products. The advantage of Borean's protein products is that they have a straightforward modular structure that is easy to re-configure. In contras...

Lantheus Medical Imaging, Inc. and NTP Radioisotopes

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which ...

Osprey Medical, Inc.

Osprey Medical is a privately held company located in Eden Prairie, Minnesota. The Company is dedicated to the treatment and prevention of ailments originating from the inter-related functioning of the heart and kidneys with a primary focus on CIN. The Company’s CINCOR™ Contrast Removal System is a catheter based system that is designed to remove ...

BioArtificial Gel Technologies

Based in Montreal (Canada), BioArtificial Gel Technologies operates in the biotechnology sector. Its mission is to develop and market systems for the progressive release of active agents based on a hydrogel technological springboard. Through intensive research, the firm has succeeded in perfecting a new generation of hydrogels for a wide range of applications. A true release vector in the form of ...

Knockouts Haircuts for Men

Headquartered in Irving, Texas, Knockouts Haircuts for Men is growing at an explosive rate, selling over 450 franchised salons in 26 states. Knockouts has been featured on NBC's Today Show, MSNBC's The Big Idea with Donny Duetsch, Fox News' Neal Cavuto Show and others. For more information, visit Knockouts' Web site at http://www.knockouts.net.

IBC Bank

IBC is the world’s leading media, entertainment and technology show. It attracts 55,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state of the art electronic media and entertainment technology.

The Center for Generational Kinetics

The Center for Generational Kinetics uncovers generational trends, truths and actionable insights that lead to powerful solutions. Our passion is helping top-tier brands tap the hidden opportunity in generational differences, with a focus on Millennials and Generation Y research. We’ve been featured on 60 Minutes, 20/20, The Today Show, The View, and ...

Confirmant Limited

Formed in June 2001, Confirmant is a joint venture between OGS and Marconi. It was conceived to develop, commercialise and market the output from OGS high throughput proteomics process.The first product resulting from this, the Protein Atlas, is due for commercial release Q3/4 2002. The Protein Atlas is a database of experimentally derived gene sequences mapped onto the human genome from the prote...

Inimex Pharmaceuticals Inc.

Inimex Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to the discovery, development, and commercialization of new medicines based on the selective modulation of the innate immune response. Inimex’ technology platform will yield novel prophylactic and therapeutic agents which will have a significant impact on management of a wide range of disease indications. Inimex...


More From BioPortfolio on "IONCs show potential next generation contrast agents"

Quick Search
Advertisement
 

Corporate Database Quicklinks